Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)
China · Delayed Price · Currency is CNY 41.43
+0.75 (1.84%)
Sep 30, 2026, 3:00 PM CST
SHA:688336 Market Cap
SHA:688336 has a market cap or net worth of 37.13 billion as of October 2, 2026. Its market cap has increased by 3.87% in one year.
Market Cap
37.13B
Enterprise Value
31.82B
Revenue
4.42B
Ranking
n/a
PE Ratio
12.08
Stock Price
41.43
ChartMarket Cap Chart
Since July 22, 2020, SHA:688336's market cap has increased from 33.34B to 37.13B, an increase of 11.38%. That is a compound annual growth rate of 1.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 37.13B | 1.06% |
| Dec 31, 2025 | 36.74B | 178.10% |
| Dec 31, 2024 | 13.21B | -4.84% |
| Dec 29, 2023 | 13.88B | 77.24% |
| Dec 30, 2022 | 7.83B | -31.47% |
| Dec 31, 2021 | 11.43B | -24.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai Allist Pharmaceuticals | 50.21B |
| Shanghai RAAS Blood Products | 35.07B |
| Beijing Wantai Biological Pharmacy Enterprise | 34.57B |
| Chongqing Zhifei Biological Products | 33.47B |
| Suzhou Zelgen Biopharmaceuticals | 29.12B |
| Beijing Tiantan Biological Products | 24.90B |
| Hualan Biological Engineering | 24.35B |
| Acrobiosystems | 23.58B |